Acquisition | LOXO ONCOLOGY INC | 21st February 2019

Due to the acquisition of LOXO ONCOLOGY INC by ELI LILLY & CO, the following treatment will be applied to the following indices.

Solactive ISS ESG Screened Developed Markets Small Cap Index

Solactive ISS ESG Screened USA Small Cap Index

Solactive Global Innovation Index

Solactive Innovative Technologies Index

Solactive US Broad Market Index

Solactive US Extended Broad Market Index

Solactive US Small & Mid Cap Index

Solactive US Large & Mid Cap Index

• LOXO ONCOLOGY INC will be removed from the Index.
• The weight of LOXO ONCOLOGY INC based on its last close price will be distributed pro rata to remaining Index constituents.
• Effective Date (open): 02/21/2019.